DECODE
Repertoire Immune Medicines, Inc.
Application Filed: 2020-04-01
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88855951 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | V03112001200 |
Timeline
| 2020-04-01 | Application Filed |
| 2020-04-08 | Location: NEW APPLICATION PROCESSING |
| 2020-04-08 | Status: Live/Pending |
| 2020-04-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Repertoire Immune Medicines, Inc. |
| Address | 26 Landsdowne Street Cambridge DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2020-04-01 |
 Drawing | JPEG | 2020-04-01 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations and therapeutic vaccines for the treatment of cancer, immune system related diseases, and infectious disease; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use; medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells; chemical agents for scientific and research use, namely, for manipulating or modifying dna; scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; technology for enabling the engineering and modification of dna, namely, molecular and cellular biology reagents, techniques and assays for the modification of cells and dna; custom development of biochemical reagents and assays |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-04-08 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-06-22 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-06-28 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-06-28 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-28 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-10-21 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-10-21 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-10-22 | 8 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-11-12 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-11-25 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-12-15 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-12-15 | 12 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2021-01-13 | 13 ETOF T:TTAB Proceeding |
| OPPOSITION INSTITUTED NO. 999999 | 2021-06-14 | 14 OP.I T:TTAB Proceeding |
| OPPOSITION DISMISSED NO. 999999 | 2023-04-19 | 15 OP.D T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2023-04-19 | 16 OP.T T:TTAB Proceeding |
| TTAB RELEASE CASE TO TRADEMARKS | 2023-04-19 | 17 TMBN T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-05-30 | 18 NOAM E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-11-27 | 19 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-11-27 | 20 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-11-27 | 21 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-11-29 | 22 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-05-24 | 23 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2024-05-24 | 24 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2024-05-24 | 25 EX2G S: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 